NCT06384911Recruiting
InvesT1D: Promoting Adolescent Investment in Diabetes Care
Source: ClinicalTrials.gov · Last updated 16 Dec 2025
Brief summary (registry, in English)
The goal of this clinical trial is to see if a financial incentives program called InvesT1D is helpful to support diabetes management in adolescents with type 1 diabetes. Adolescent participants will be randomized to usual care or receive financial incentives for meeting diabetes self-management and clinical outcomes goals during the study. Researchers will compare changes in glucose levels, as well as adolescent and caregiver person-reported outcomes between groups.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 96 (estimated)
- First submitted
- 22 Apr 2024
- Start date
- 25 Jun 2024
- Primary completion date
- 31 Jul 2027
- Lead sponsor
- Harvard Pilgrim Health Care
- Diseases
- Type 1 diabetes
- NCT number
- NCT06384911
What you commit to
- Study type: Interventional
- Planned participants: 96
- From 25 Jun 2024 to the primary completion date, 31 Jul 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Adolescent is not interested in using diabetes technology that allows for tracking of bolus insulin administration if participant wants to work on improving daily bolus insulin administration
- Severe comorbidities including other major chronic health conditions that significantly impact daily management demands or health outcomes
Other
- At time of screening, average CGM wear is greater than 70% of the time or baseline average insulin bolus administration is greater than 3 times a day
- Cognitively or physically unable to participate
- Adolescent is a ward of the state
- Caregivers are not willing to participate in study and complete surveys
Who the study is looking for
- Diagnosed with type 1 diabetes ≥12 months
- Utilize a continuous glucose monitor (CGM) to support diabetes management
- Average daily CGM use is less than or equal to 70% of the time and/or their baseline average insulin bolus administration is less than or equal to 3 times a day
- Are using diabetes technology that allows for tracking of bolus insulin administration if participant wants to work on improving daily bolus insulin administration
- Cognitively able to participate in incentive program and complete surveys
- Have access to a mobile phone to receive information about goal attainment and incentive updates
- Have the ability to upload glucose and insulin administration data remotely per processes used by participant's diabetes care team
- Caregivers are willing to participate in study and complete surveys
Age in the registry: 12 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Seattle Children's Coordinator of this site? Confirm its status | Seattle | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.